L-869298

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameL-869298
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast growth factor receptor 4 antagonists
TargetsFibroblast growth factor receptor 4
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthmaArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Frosst Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Frosst Company
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic ObstructiveAsthmaArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A